找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Resistant Hypertension; Massimo Salvetti Book 2016 Springer International Publishing Switzerland 2016 Difficult-to-treat hypertension.Fals

[复制链接]
楼主: 恳求
发表于 2025-3-23 10:43:41 | 显示全部楼层
发表于 2025-3-23 14:05:25 | 显示全部楼层
发表于 2025-3-23 21:32:03 | 显示全部楼层
发表于 2025-3-24 00:55:19 | 显示全部楼层
Adult Patient with Pseudo-Resistant Hypertension: Spurious Resistant Hypertension,ue resistance to treatment. In fact, studies have shown that up to one third of patients with suspected resistant hypertension have normal 24-h (or home) blood pressure values and that these patients have much less organ damage and a better prognosis as compared to “true resistant” hypertensives.
发表于 2025-3-24 05:02:44 | 显示全部楼层
发表于 2025-3-24 10:21:20 | 显示全部楼层
Adult Patient with Pseudo-Resistant Hypertension: High Blood Pressure Induced by Exogenous Substancfactors responsible for poor BP control. In these patients, after the assessment of adherence to lifestyle measures and to drug treatment, the diagnostic workup should include the evaluation of possible secondary forms of hypertension. An accurate evaluation of the drugs and substances assumed by th
发表于 2025-3-24 12:51:17 | 显示全部楼层
发表于 2025-3-24 16:35:13 | 显示全部楼层
Adult Patient with Pseudo-Resistant Hypertension: Drug Intolerance,ved. Today, several classes of effective antihypertensive drugs are available, and in particular ACE inhibitors, angiotensin II receptor blockers, calcium antagonists, diuretics and beta blockers are all considered first-line drugs by current European Guidelines; furthermore, other molecules may be
发表于 2025-3-24 21:38:02 | 显示全部楼层
发表于 2025-3-25 02:12:33 | 显示全部楼层
Adult Patient with Resistant Hypertension Secondary to Comorbidities,ic. Lifestyle was certainly not optimal in this obese patient. Obesity and overweight are quite common in patients with BP elevation, being present in about 75 % of the hypertensive patients seen by general practitioners or specialists. Together with combination treatment with antihypertensive drugs
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-14 19:52
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表